AGRANULOCYTOSIS IN PATIENTS TREATED WITH THORAZINE
Abstract
This case demonstrates two points to be remembered with Thorazine; namely, that the dosage does not have to be high to produce agranulocytosis in susceptible patients, and that even when Thorazine has been withdrawn and replaced by energetic treatment and agranulocytosis hematologically resolved, the clinical course may be fatal.
We are not sure what part had been played by the patient's pulmonary emphysema and cerebral aneurysm in her clinical condition.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
